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Pancreatic cancer (PC) is one of the most lethal cancers and 12th most com-
mon cancer in the world. Due to the inaccessible anatomical position of the
pancreas and asymptomatic early stages of this disease, PC has a high mortal-
ity rate. Therefore, providing reliable diagnostic and therapeutic tools are the
keys to increase the PC survival rate. Nanotechnology is an inchoate field of
science that previously scientists' tendency to enhance the efficacy of current
preventive, diagnostic, and therapeutic methods has oriented them to build a
bridge between this science and medicine. In the case of PC, nanotechnology
suggests using drug delivery devices for a more effective and targeted therapy.
Chitosan is a natural polymer that recently has attracted a lot of attention for
being renewable, nontoxic, and bioabsorbable. In this article, we tend to look
for the answer to this question: has nanotechnology been successful in using
chitosan-based nanoformulations as carriers for preventing more individuals
from suffering or at least increasing the 5-year survival of the PC patients?
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1 | INTRODUCTION
The pancreas is one of the most critical components of the
body that is located behind the stomach in the abdomen
and is divided into a head, neck, body, and tail.1 The
importance of this organ is because of its twofold function
in the endocrine and digestive system. As a result, the pan-
creas is made up of two parts with different cells and func-
tions: an endocrine and an exocrine part. The endocrine
component is known for its hormone secretion such as
insulin, glucagon, somatostatin, and pancreatic polypeptide
and its role in blood sugar-regulating and the exocrine
component has an essential part in the digestion of fats,
carbohydrates, and proteins in the duodenum.1 These data
show that any disturbance in this organ would disarrange
the function of the digestive and endocrine system and
would put the patient's body in a lot of problems.
Pancreatic cancer (PC) is one of the many complica-
tions that take place in the pancreas. We put the name of
PC on a malignant condition in which accidental muta-
tions occur in the growth regulator genes of the pancre-
atic somatic cells. These mutated somatic cells disturb
the balance of pancreas performance by invading,
wreaking, and eroding its normal cells.2 This cancer is
one of the most lethal cancers around the world in which
its mortality rate is approximately 100% and in the best
condition, its 5-year survival rate was reported only 9%
(in 2019).3–5 Nutritional and metabolic derangements6,7
Abbreviations: antiHER2, Antihuman epidermal growth factor
receptor-2; c-SLN, chitosan-coated solid lipid nanoparticles; DD,
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gemcitabine; IL-2, interleukin-2; NPs, nanoparticles; PC, pancreatic
cancer; VEGF, vascular endothelial growth factor.
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